Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-?-Reference-Cited by-同舟云学术

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-?

Published:1995-12 Issue:12 Volume:121 Page:753-756
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Canobbio Luciano,Rubagotti Alessandra,Miglietta Loredana,Cannata Daniela,Curotto Antonio,Amoroso Domenico,Boccardo Francesco

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01213322.pdf

Reference23 articles.

1. Atzopodien J, Poliwoda H, Kirchner H (1991) Alpha-interferon and interleukin-2 in renal cell carcinoma: studies in nonhospitalized patients. Semin Oncol 18 [Suppl 7]:108?112

2. Buter J, Sleijfer DT, Graaf WTA van der, Vries EGE de, Willemse PHB, Mulder NH (1993) A progress report on the outpatient treatment of patients with advanced renal cell carcinoma using subcutaneous recombinant interleukin-2. Semin Oncol 20 [Suppl 9]:16?21

3. Buzaid AC, Todd MB (1989) Therapeutic options in renal cell carcinoma. Semin Oncol 16:12?19

4. Cox DR (1972) Regression models and life tables (with discussion). J R Statist Soc [B] 34:187?202

5. Elson PJ, Witte RS, Trump DL (1988) Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48:7310?7313

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Better survival in patients with metastasised kidney cancer after nephrectomy: A population-based study in the Netherlands;European Journal of Cancer;2011-09

2. Prognostic factors for survival in metastatic renal cell carcinoma;Cancer;2009-04-28

3. Prognostic Factors for Survival in Metastatic Renal Cell Carcinoma;Clinical Management of Renal Tumors;2008

4. Prognostic Factors in Patients with Advanced Renal Cell Carcinoma;Clinical Cancer Research;2004-09-15

5. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma;Urology;2003-02